Besides PSA, other biomarkers such as prostate specific membrane antigen (PSMA), PF-4, IL-6, and ANXA3 can also be used for prostate cancer diagnosis, which have been tested using nanomaterials (Chikkaveeraiah et al., 2009; Kim et al., 2013). This evidence concerns the gene KLK3 and prostate carcinoma.